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We investigated the mechanism underlying the protective effects of ginger against gastric 
damage induced by aspirin in rats.  Gastric mucosal lesions were produced by orally ad-
ministering 200 mg/kg aspirin suspended in 1% carboxymethylcellulose solution to pylo-
ric-ligated male Wistar rats.  Ginger powder (200 mg/kg) markedly reduced the aspirin-
induced gastric hemorrhagic ulcer area.  The total acidity of gastric juice was not signifi-
cantly influenced by aspirin or ginger.  Ginger powder did not affect the aspirin-induced 
reduction in mucosal prostaglandin E2 (PGE2) content; however, it did ameliorate the 
aspirin-induced increases in mucosal activity of the inducible form of NO synthase (iNOS) 
and plasma tumor necrosis factor (TNF)-  and interleukin (IL)-1  levels.  In the next ex-
periment, high and low doses of 6-gingerol and 6-shogaol were used instead of ginger pow-
der in the same experimental model to examine their roles in the anti-ulcer mechanism of 
ginger.  Both 6-gingerol and 6-shogaol reduced aspirin induced ulcer formation, mucosal 
iNOS and plasma TNF-  and IL-1  levels.  In conclusion, ginger powder prevents the as-
pirin induced gastric ulcer formation by reducing mucosal iNOS activity and the plasma 
levels of inflammatory cytokines but does not affect gastric juice or acid production or mu-
cosal PGE2 content.  This protective effect of ginger powder against gastric ulcers may be 
attributable to both gingerol and shogaol. 
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Aspirin is a potent nonsteroidal anti-inflammatory 
drug (NSAID) that is used for the treatment of 
rheumatoid arthritis and related diseases as well as 
the prevention of cardiovascular thrombotic diseas-
es.  Gastric ulcer associated with the use of aspirin 
is a major problem.  Many factors such as gastric 
acid and pepsin secretion, gastric microcircula-
tion, prostaglandin E2 (PGE2) content (Laine et al., 
2008), and proinflammatory cytokines interleukin 
(IL)-1  and tumor necrosis factor (TNF)-  (Santucci 
et al., 1995; Appleyard et al., 1996) play important 
roles in the genesis of gastric mucosal damage, 
and its subsequent development (Wang et al., 2007; 
Wallace, 2008).  It has been reported that increases 
in NO synthase (NOS) activity is involved in the 
gastrointestinal mucosal defense and also in the 
pathogenesis of mucosal damage (Muskara et al., 
1999; Wallace et al., 2000). 
 Ginger (Zingiber officinale) has been used 
as a spice and an ingredient of Chinese traditional 
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stomach medicine for thousands of years.  In tra-
ditional medicine, ginger has been used to treat 
many inflammatory conditions and associated pain 
(Altman and Marcussen, 2001).  The major pungent 
constituents of ginger, 6-gingerol and 6-shogaol, 
have been shown to have many interesting phar-
macological effects, such as anti-oxidant, anti-
tumor promoting and anti-inflammatory effects 
(Surh, 2002; Kim et al., 2005; Young et al., 2005). 
However, the mechanism underlying the protective 
effects of ginger against gastric damage is unclear. 
Here, we investigated the antiulcer effects of ginger 
in aspirin-induced gastric ulcer model rats.
 
Materials and Methods 
Animal experiment using ginger powder
 
The experimental protocol was approved by the 
ethics committee on animal experiments in Tottori 
University, and the experiments were carried out in 
accordance with the guidelines for animal experi-
ments in the same facility.
 Male Wistar rats at 8 weeks of age (weigh-
ing 300–350 g) were purchased from Shimizu 
Laboratory Supplies (Kyoto, Japan).  They were 
acclimated in an air-conditioned room at 25˚C and 
55% humidity and given standard chaw for a few 
days.  Before surgery, the rats were fasted for 24 h 
and allowed free access to drinking water.  Then, 
the animals were anesthetized using pentobarbi-
tal (30 mg/kg body weight, intraperitoneally), the 
abdomen was opened, and the pyloric end of stom-
ach was ligated without causing any damage to its 
blood supply.  The stomach was then replaced, and 
the abdominal wall was closed in two layers with 
sutures.  
 After they had fully recovered from the anes-
thesia, the animals were divided into 4 groups of 
five animals each.  Group 1 orally received 3 mL 
of 1% carboxymethylcellulose in water (vehicle) 
by gavage.  Group 2 orally received ginger powder 
(200 mg/kg body weight) suspended in 3 mL of 1% 
carboxymethylcellulose in water.  Group 3 orally 
received aspirin (200 mg/kg body weight) suspend-
ed in 3 mL of 1% carboxymethylcellulose in water. 
Group 4 orally received aspirin together with gin-
ger powder suspended in 3 mL of 1% carboxym-
ethylcellulose in water.  At 4 h after the test drug 
administration, the animals were anesthetized, and 
then blood was collected from the heart, and the 
stomach was removed after the esophageal end had 
been tied (Jainu and Devi, 2006; Jainu et al., 2006). 
The stomach was cut open along the greater curva-
ture, and the contents were collected in tubes and 
centrifuged at 200 × g for 10 min.  The resultant 
supernatant was used for the estimation of acid and 
gastric juice output.  The stomach was then washed 
with warm saline, and the inner surface was photo-
graphed to allow the measurement of the area cov-
ered by hemorrhagic ulceration.  Next, the gastric 
mucosal tissues were removed, frozen in liquid ni-
trogen and stored at –80˚C.  The total acid content 
of the gastric juice was determined by titrating it 
with 0.01 N NaOH, using phenolphthalein as indi-
cator, and was expressed as mEq/4 h/100 g (Jainu 
et al., 2006; Wang et al., 2007).  The acidity of gas-
tric juice was calculated as total acid content/gastric 
juice volume in mEq/mL (Khushtar et al., 2009). 
 In animal experiments using 6-gingerol and 
6-shogaol, the same procedures as were used in 
the first experiment to produce the pylorus ligated 
rats were repeated using high dose (2 mg/kg) and 
low dose (1 mg/kg) 6-gingerol, and high dose (1 
mg/kg) and low dose (0.5 mg/kg) 6-shogaol, in-
stead of ginger powder suspended in 3 mL of 1% 
carboxymethylcellulose in water.  The doses of 
6-gingerol and 6-shogaol used in the experiment 
were determined by those found in normal ginger 
(Schwertner and Rios, 2007).
 
Quantification of the gastric hemorrhagic 
ulcer area using NIH image
 
The photographs of the stomach were digitized and 
converted to binary images through gray scale im-
aging (Khan, 2004).  Using the National Institute 
of Health (NIH) image-J software, the area of gas-
tric hemorrhagic ulcers (mm2) was calculated. 
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Histological studies
 
Gastric tissue samples from each group were fixed 
in 10% formalin for 24 h.  The specimens were 
then embedded in paraffin, sectioned and stained 
with hematoxylin and eosin, before being evaluated 
by light microscopy.  
 
Measurement of mucosal PGE2
 
Frozen gastric mucosal tissue (1 g) was added to 5 
mL homogenization buffer (0.1 M phosphate (pH 
7.4), containing 1 mM EDTA and 10 μM indo-
methacin) and homogenized.  The lysate was then 
centrifuged in a microcentrifuge at 16,000 × g for 
15 min at 2˚C to 8˚C. The supernatant was trans-
ferred to a new tube, and its total protein content 
was analyzed using the advanced protein assay. 
PGE2 concentrations were investigated using the 
PGE2 ELISA Kit (R&D Systems, Minneapolis, 
MN). 
 
Measurement of iNOS activity
 
Individual specimens of the gastric mucosa were 
homogenized in sample buffer containing 10 mM 
EDTA and centrifuged at 13,000 × g at 4˚C for 5 
min.  The supernatant was transferred to a new 
tube and had a total protein content of 10 μg/μL. 
Gastric mucosal iNOS activity was measured with 
the NOS-detect assay kit (Agilent Technologies, 
Santa Clara, CA).
 
Determination of plasma TNF-  and IL-1  
levels
 
Blood samples in EDTA-containing vials were cen-
trifuged at 1000 × g for 10 min at 4˚C.  The levels 
of IL-1  and TNF-  were determined by ELISA 
according to the manufacturer’s instructions (Assay 
Designs, Ann Arbor, MI; Bender MedSystems, San 
Diego, CA). 
  
 
 
Reagents
 
Aspirin was purchased from Sigma Chemical (St. 
Louis, MO).  Carboxymethylcellulose sodium salt, 
6-gingerol and 6-shogaol were purchased from 
Wako Pure Chemical Industries (Osaka, Japan). 
The ginger powder was a generous gift from Ya-
wata Bussan (Yonago, Japan).  It has been con-
firmed that 100 g of ginger powder contains 0.68 g 
of 6-gingerol (Japan Food Research Laboratories, 
Tokyo, Japan). 
 
Statistical analysis
 
All values are expressed as the mean ± SEM.  All 
results were analysed by one way analysis of vari-
ance followed by the proper post-hoc test by SPSS 
11.0 J (SPSS Japan, Tokyo).  P < 0.05 was consid-
ered statistically significant.
 
Results
 
Aspirin-induced gastric hemorrhagic ulcer 
formation 
 
The macroscopic findings of the opened stomach 
are shown in Fig. 1a.  Hemorrhagic gastric ulcers 
covered with coagulated blood were more apparent 
in the aspirin administered group (Aspirin, Group 
3) than the control (Control, Group 1).  Ginger 
powder alone (Ginger, Group 2) had no effects on 
the stomach, and the coadministration of ginger 
powder with aspirin inhibited aspirin-induced ulcer 
formation (Aspirin + Ginger, Group 4).  Figure 1b 
shows the mean area of gastric hemorrhagic ulcers 
in each group.  Even in the control conditions, pin-
point ulcers were sometimes seen.  Aspirin-induced 
ulcer formation was completely inhibited by the 
coadministration of ginger powder (P < 0.01).
 
Histopathological findings of gastric mu-
cosa
 
The histopathological findings of the gastric mu-
cosa are shown in Fig. 2.  The gastric mucosa 
obtained from the control (Group 1) rats showed 
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an intact cellular architecture (not shown).  Ulcers 
combined with distorted gastric glands, a dam-
aged mucosal epithelium, inflammatory exudates 
and cellular debris were found in the stomachs 
of the aspirin-treated rats (Fig. 2a, Aspirin).  The 
protection against these histopathological changes 
induced by the coadministration of ginger powder 
Fig. 1.  Effects of ginger powder against aspirin-induced 
gastric ulcers in rats. 
 a: Photographs of the gastric mucosa in the control 
group and the ginger, aspirin and aspirin with ginger 
treatment groups are shown.  
b:  The hemorrhagic ulcer area (cm2) measured in each 
condition.  In this and the following figures, values 
are shown as the mean ± SEM.  **P < 0.01 com-
pared with the control rats.  ##P < 0.01 compared 
with the aspirin-treated rats.
Fig. 2.  Histological examinations of gastric mucosal tissue.  Ulcer formation with distorted gastric glands, a damaged 
mucosal epithelium and cell debris are shown in a (Aspirin); however, the coadministration of ginger with aspirin pro-
tected against these changes, as shown in b (Aspirin + Ginger) (hematoxylin and eosin stain).  Bar = 500 µm.
to rats resulted in the maintenance of glandular 
organization and the structure of the muscularis 
mucosa (Fig. 2b, Aspirin + Ginger).  The histologi-
cal examination of the ginger powder alone-treated 
rats showed a normal cellular architecture in the 
gastric mucosa with no pathological changes (not 
shown).
a
Aspirin + GingerAspirinGingerControl
Aspirin + GingerAspirin
ba
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Gastric juice and acid production
 
Both ginger and aspirin reduced gastric juice pro-
duction /100 g body weight.  However this effects 
disappeared by coadministration of ginger and as-
pirin.  The total acidity showed no significant dif-
ferences among these conditions (Table 1).
  
 
   
Mucosal PGE2 levels
 
The gastric mucosal PGE2 contents measured in 
each condition are compared in Fig. 3.  Aspirin 
reduced the mucosal PGE2 content, and the coad-
ministration of ginger powder failed to inhibit the 
aspirin-induced reduction of PGE2 content.
 
Mucosal iNOS expression
 
Aspirin administration led to a significant increase 
in gastric mucosal iNOS activity in the ulcerated 
rats as compared to that measured in the control or 
ginger administered rats (Fig. 4).  The coadmin-
istration of ginger powder resulted in a significant 
decrease in gastric mucosal iNOS activity com-
pared with that observed in the aspirin alone group 
(P < 0.05).  No differences were seen in iNOS lev-
els between the ginger powder treated Group 2 and 
Group 1 (control).
 
Expression of TNF-  and IL-1  in plasma
 
The plasma concentrations of TNF-  and IL-1  in 
the rats are shown in Fig. 5.  The concentrations 
of TNF-  and IL-1  were significantly increased 
after the administration of aspirin compared with 
those seen in the control rats (Aspirin, Figs. 5a and 
b).  Ginger powder attenuated these increases in the 
plasma levels of TNF-  and IL-1 , even after the 
coadministration of aspirin in rats (Ginger + Aspi-
rin, Figs. 5a and b).
Table 1.  Effects of ginger powder on gastric 
mucosal factors in experimental gastric ulcer 
model rats
Group Parameter
 Volume of gastric juice  Acidity 
 (mL/100 g) (mEq/mL)
Control 6.15 ± 1.3 52.54 ± 11.54
Ginger  3.03 ± 0.27* 47.85 ± 12.40 
Aspirin 3.80 ± 0.42* 46.71 ± 0.37
Aspirin + Ginger 6.20 ± 0.72# 50.25 ± 7.02
 Values are shown as the mean ± SEM.  
* P < 0.05 compared with the control rats.  
# P < 0.05 compared with the aspirin group.
Fig. 3.  Effects of ginger powder on the PGE2 level of the 
gastric mucosal tissue.  Aspirin administration reduced 
the PGE2 level, and the coadministration of ginger powder 
(200 mg/kg) for 4 h failed to inhibit the reduction in the 
PEG2 level.  **P < 0.01.  NS, not significant; PGE2, pros-
taglandin E2 (pg/mL).
Fig. 4.  Effects of ginger powder in iNOS activity in the 
gastric mucosa.  The coadministration of ginger powder 
(200 mg/kg) inhibited the increase in iNOS activity in-
duced by aspirin alone.  **P < 0.01 compared with the 
control rats.  #P < 0.05 compared with the aspirin-treated 
rats.  iNOS, inducible form of NO synthase (dpm/10 mg).
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Fig. 5.  Effects of ginger powder on the plasma levels of 
TNF-  and IL-1 .  The aspirin-administered rats showed 
marked increases in their plasma TNF-  and IL-1  levels. 
The coadministration of ginger powder completely inhib-
ited these marked increases in TNF-  (a) and IL-1  (b) 
levels.  *P < 0.05, **P < 0.01compared with the control 
rats.  #P < 0.05, ##P < 0.01 compared with the aspirin 
administered rats.  TNF- , tumor necrosis factor- ; IL-1 , 
interleukin-1 .
Fig. 6.  Effects of 6-gingerol and 6-shogaol on the gastric 
mucosal lesion formation induced by aspirin in rats.  Both 
6-gingerol and 6-shogaol inhibited the gastric ulcer forma-
tion induced by aspirin.  The animals were treated alone with 
2 mg/kg 6-gingerol (Gingerol), 1 mg/kg 6-shogaol (Shogaol), 
200 mg/kg aspirin (Aspirin); and treated combinedly 
with Aspirin and 1 mg/kg 6-gingerol (lowG), 2 mg/kg 
6-gingerol (highG), 0.5 mg/kg 6-shogaol (lowS), 1 mg/kg 
6-shogaol (highS).  **P < 0.01 compared with the control. 
#P < 0.05 compared with the aspirin-induced rats.
 
Effects of 6-gingerol and 6-shogaol in the 
presence of aspirin
 
High and low doses of 6-gingerol and 6-shogaol, 
the major constituents of ginger powder, had no ad-
verse effects on the stomach and inhibited the ulcer 
formation induced by aspirin (Fig. 6).  6-Gingerol 
and 6-shogaol exerted inhibitory effects on the as-
pirin induced increases in mucosal iNOS activity 
(Fig. 7) and plasma TNF-  and IL-1  levels (Fig. 8) 
in the same manner as ginger powder. 
 
 
Discussion
 
Ginger has been used as an ingredient of Chinese 
traditional stomach medicines for thousands of 
years.  The anti-ulcerative effects of ginger have 
previously been investigated in experimental gas-
tric ulcer models (Yamaha et al., 1988; al-Yahva 
et al., 1989; Khushtar et al., 2009).  However, the 
mechanism underlying the protective effects of 
ginger against gastric damage is unclear.  In the 
present study, the anti-ulcerative effects of ginger 
powder were investigated in aspirin-induced gastric 
ulcer model rats.  Aspirin has been reported to re-
duce the gastric juice pH and increase the volume 
of gastric juice (Wang et al., 2007), or decrease the 
volume of gastric juice and its acid output (Jainu 
et al., 2006).  In the present study, the volume of 
gastric juice and acid output/100 g body weight for 
4 h reduced by aspirin and recovered by the coad-
ministration of ginger with aspirin.  The acidity of 
gastric juice was not significantly changed by any 
treatments.  Our results suggest that the changes 
in the volume of gastric juice and acid production 
induced by aspirin are not a major factor in ulcer 
formation or the protective effects of ginger powder 
seen in these experimental ulcer model rats. 
 Prostaglandins have protective effects against 
various gastric injury models (Wallace, 1992; 
Brzozowski et al., 2005).  Aspirin has been shown 
to reduce the mucosal PGE2 content (Takeuchi et 
al., 1986; Lichtenberger et al., 2007; Wang et al., 
2007).  The lack of attenuation of the decrease in 
gastric mucosal PGE2 content after the coadminis-
tration of ginger powder also reveals that the resto-
ration of the PGE2 level in the gastric mucosa is not 
17
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Fig. 8.  Effects of 6-gingerol and 6-shogaol on the plasma 
levels of TNF-  and IL-1 .   The effects of high and low 
doses of 6-gingerol or 6-shogaol were examined during 
their coadministration with aspirin.  The increases in 
plasma TNF-  (a) and IL-1  (b) levels induced by aspirin 
were reduced by the coadministration of these constitu-
ents.  **P < 0.01 compared with the control.  #P < 0.05, 
##P < 0.01 compared with the aspirin-treated rats.  The 
definition of groups, refer to the legends for Fig. 6.
Fig. 7.  Effects of 6-gingerol and 6-shogaol on iNOS ac-
tivity in the gastric mucosa.  The effects of aspirin on the 
iNOS activity in the gastric mucosa were compared in the 
absence and the presence of high and low doses of 6-gin-
gerol or 6-shogaol.  **P < 0.01, compared with the control 
rats.  #P < 0.05, ##P < 0.01 compared with the aspirin-
treated rats. iNOS, inducible form of NO synthase.  The 
definition of groups, refer to the legends for Fig. 6.
mucosa leads to a reduction in gastric mucosal 
damage (Konturec et al., 2006).  In the present 
study, ginger powder reduced iNOS activity and in-
hibited the production of gastric ulcers, even in the 
presence of aspirin. 
 Inflammation and neutrophil infiltration are 
also important in the pathogenesis of the gastric 
damage induced by NSAIDs (Wallace et al., 1990; 
Lee et al., 1992; Trevethick et al., 1993; Souza et 
al., 2004).  The inflammation induced in the gastric 
mucosa by aspirin is accompanied by increased 
TNF-  production (Naito et al., 2001; Jainu and 
Devi, 2006), which augments neutrophil-derived 
superoxide generation (Kwiecieñ et al., 2002) and 
stimulates IL-1  production, leading to neutrophil 
accumulation (Kokura et al., 2000; Odashima et 
al., 2006).  In the present study, the levels of TNF-
 and IL-1  were increased by aspirin administra-
tion, and the coadministration of ginger powder 
inhibited the increases in TNF-  and IL-1  without 
ulcer formation progressing.  These effects re-
the mechanism underlying the protective effects of 
ginger powder in this aspirin induced ulcer model. 
This is not unexpected because the reduction of the 
gastric mucosal PGE2 concentration induced by as-
pirin does not necessarily participate in gastric ul-
cer generation (Takeuchi et al., 1986; Lichtenberger 
et al., 2007).
 One of the mechanisms by which aspirin 
damages the gastric mucosa is the increased pro-
duction of NO due to the overexpression of iNOS 
(Kontureck et al., 2006).  NO is a mediator not 
only of gastrointestinal mucosal defense (Calatayud 
et al., 2001), but also of its damage (Muscara and 
Wallace, 1999).  It has been shown that different 
concentrations of NO have completely opposite ef-
fects in the same tissue (Wallace and Millor, 2000). 
In general, the mucosal and endothelial NOS iso-
forms produce low amounts of NO.  However, the 
high quantity of NO produced by iNOS damages 
the epithelium (Piotrowski et al., 1999; Wallace 
and Miller, 2000).  The excessive release of NO 
from gastric epithelial cells induced by aspirin has 
been reported to exert detrimental effects (Whittle, 
2003; Hsu and Liu, 2004).  Inhibiting aspirin-
induced increases in iNOS expression in the gastric 
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sembled those induced by pretreatment with Cissus 
quadrangularis extract for 7 days (Jainu and Devi, 
2006).
 Then, the anti-inflammatory effects of the 
main constituents of ginger were examined using 
the same experimental protocol.  In the previ-
ous study, 6-gingerol, 6-shogaol, 8-gingerol and 
10-gingerol have been identified as the principal 
components of ginger powder (Chen et al., 1986). 
6-Shogaol, a dehydration product of 6-gingerol, 
is found in ginger powder but not in fresh ginger 
powder.  6-Shogaol appears to be formed from 
6-gingerol during thermal processing and long-
term storage (Chen et al., 1986).  In general, the 
ability of compounds was related to both the length 
of the side chain and to the parent compound (gin-
gerol versus shogaol).  According to the relatively 
similar potency for several effects, their contribu-
tion on the effects of ginger may depends on their 
amounts.  Therefore, several studies have focused 
on the effects of major components, 6-gingerol 
and 6-shogaol.  The anti-inflammatory effects of 
6-gingerol have been examined in the acetic acid-
induced writhing response in mice and carrageen-
an-induced rat paw edema model (Young et al., 
2005).  Lipopolysaccharide (LPS) induced PGE2 
production was inhibited by treatment with either 
gingerol or shogaol (Lantz et al., 2007).  Shogaol 
has been reported to markedly inhibit the LPS-
induced expression of iNOS and COX-2 (Pan et al., 
2008) and to have no effect on COX-2 expression 
(Lantz et al., 2007), whereas gingerol was found 
to inhibit LPS-induced COX-2 expression (Lantz 
et al., 2007). Both gingerol and shogaol have been 
shown to inhibit TNF-  mediated actions at the 
cellular level (Lantz et al., 2007; Isa et al., 2008). 
In the present study, both constituents of ginger 
showed protective effects against aspirin-induced 
gastric ulcers together with anti-inflammatory ef-
fects.  We failed to show the dose dependency on 
the anti-inflammatory effects of these constituents; 
however, the rather high concentrations of these 
compounds used may explain this result. 
 From these results, ginger powder is suggested 
to protect the stomach against the ulcer formation 
induced by aspirin by reducing iNOS activity in the 
gastric mucosa and inflammatory cytokine (TNF-
 and IL-1 ) expression.  These effects of ginger 
powder seem to be derived from the actions of gin-
gerol and shogaol, the main ingredients of ginger.  
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